Dehydroepiandrosterone (Dhea) Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 25 mg, 50 mg, and 100 mg
Reference Brands: Generics & generic brands available in US & EU
Category:
Sexual Wellness
Dehydroepiandrosterone (DHEA) is a hormone precursor that converts into androgens and estrogens, supporting hormonal balance. It may improve libido, boost energy, enhance mood, support bone density, and reduce aging symptoms. Benefits include improved overall vitality, healthier aging, and potential metabolic regulation.
Dehydroepiandrosterone (DHEA) tablets is available in Tablets
and strengths such as 25 mg, 50 mg, and 100 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Dehydroepiandrosterone (DHEA) tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Dehydroepiandrosterone (DHEA) tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Dehydroepiandrosterone (DHEA) tablets, available as generics and marketed under various brand names, are used in the US and EU as dietary supplements and hormone support therapies. Regulatory requirements for DHEA differ: in the US, it is considered a dietary supplement regulated by the FDA, whereas in the EU, it may require compliance with regional supplement and medical device regulations. Dossier preparation must include safety data, manufacturing standards, and quality controls.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing